Short-term data from NOTION-2: TAVR vs SAVI for younger patients with aortic stenosis - EuroPCR 2024

Presented by Ole De Backer at EuroPCR 2024, this study provides further data concerning the 1-year outcome of younger AS patients with tricuspid valve anatomy treated with #TAVI compared to #SAVR. Both showed similar rates of the primary endpoint at 1 year, but this interpretation is limited by the small sample size.
It also provides a “word of caution” concerning the use of TAVI in younger AS patients with bicuspid valve anatomy: dedicated trials comparing optimal TAVI with SAVR in younger patients with bicuspid aortic valve stenosis are now required.

More news: https://www.pcronline.com/News/Whats-new-on-PCRonline/

Видео Short-term data from NOTION-2: TAVR vs SAVI for younger patients with aortic stenosis - EuroPCR 2024 канала PCR